US4665202A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Flavene and thioflavene derivatives
Assignee: Haleon CH SARL
•
Filing: 1984-08-24
•
Granted: 1987-05-12
•
Expires: 2004-08-24
Abstract
Abstract The invention relates to pharmaceutical preparations containing compounds of formula I ##STR1## in which X 1 and X 2 , independently of each other, represent hydrogen, halogen, unsubstituted or substituted amino or a quaternary ammonium salt; etherified or esterified hydroxy; free, etherified, esterified or oxidized mercapto; nitro; functionally modified formyl; free or functionally modified carboxyl; acyl; an unsubstituted or substituted hydrocarbon radical, or an unsubstituted or substituted heterocyclic radical; with the proviso that at least one of the radicals X 1 and X 2 is bonded by a carbon atom to the ring system and with the proviso that X 1 and X 2 cannot be together halogen and formyl; in which Y represents oxygen, sulfur, sulfinyl or sulfonyl but must be sulfur, sulfinyl or sulfonyl, if X 1 is hydrogen and X 2 is formyl, and the rings A and B are each unsubstituted or substituted; or pharmaceutically acceptable salts of such compounds that contain a salt-forming group, and to novel compounds of formula I. The compounds are useful e.g. for the treatment of diseases of the respiratory tract and of liver diseases. The are prepared by methods known per se.
Inventors
- 👤 Christian G. Rimbault
- 👤 Philippe M. Narbel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 11:32
CPC Classifications
C; C07; C07D; C07D335/00; C07D335/04; C07D335/06; A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35; A61K31/38; A61P; A61P1/00; A61P1/16; A61P11/00; A61P37/00; C07D311/00; C07D311/02; C07D311/04; C07D311/58; C07D311/60; C07D311/64; C07D311/68
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
191 words
A compound of the formula ##STR11## wherein one of the radicals X 1 and X 2 is selected from the group (a) consisting of formyl; imino lower alkyl which is unsubstituted or substituted by hydroxy or phenyl; carboxy; cyano; lower alkylcarbonyl which is unsubstituted or substituted by halogen; lower alkyl which is unsubstituted or substituted by hydroxy; the other of X 1 and X 2 is selected from the group (b) consisting of hydrogen; halogen; amino; lower alkyl amino or di-lower alkyl amino, the lower alkyl portion thereof being unsubstituted or substituted by carboxy or lower alkoxycarbonyl; lower alkylene amino; aza-lower alkylene amino; oxa-lower alkylene amino; thia lower alkylene amino; phenylamino; lower alkoxy; lower alkylthio which is unsubstituted or substituted by carboxy or lower alkoxycarbonyl; benzylthio; and 2H-3-formyl-2-phenyl-1-benzopyran-4-yl-thio; Y is oxygen or sulfur, but must be sulfur if X 1 is hydrogen and X 2 is formyl or lower alkyl; and rings A and B are independently unsubstituted or substituted by a substituent selected from lower alkyl, lower alkoxy, halogen and nitro; provided that X 1 and X 2 cannot be together halogen and formyl; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
191 words
A compound of the formula ##STR11## wherein one of the radicals X 1 and X 2 is selected from the group (a) consisting of formyl; imino lower alkyl which is unsubstituted or substituted by hydroxy or phenyl; carboxy; cyano; lower alkylcarbonyl which is unsubstituted or substituted by halogen; lower alkyl which is unsubstituted or substituted by hydroxy; the other of X 1 and X 2 is selected from the group (b) consisting of hydrogen; halogen; amino; lower alkyl amino or di-lower alkyl amino, the lower alkyl portion thereof being unsubstituted or substituted by carboxy or lower alkoxycarbonyl; lower alkylene amino; aza-lower alkylene amino; oxa-lower alkylene amino; thia lower alkylene amino; phenylamino; lower alkoxy; lower alkylthio which is unsubstituted or substituted by carboxy or lower alkoxycarbonyl; benzylthio; and 2H-3-formyl-2-phenyl-1-benzopyran-4-yl-thio; Y is oxygen or sulfur, but must be sulfur if X 1 is hydrogen and X 2 is formyl or lower alkyl; and rings A and B are independently unsubstituted or substituted by a substituent selected from lower alkyl, lower alkoxy, halogen and nitro; provided that X 1 and X 2 cannot be together halogen and formyl; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
93 words
The compound of claim 1 wherein one of X 1 and X 2 is selected from the group consisting of formyl; carboxy; cyano; halogeno lower alkyl carbonyl; hydroxy lower alkyl; and hydroxy imino lower alkyl; the other of X 1 and X 2 being selected from the group consisting of hydrogen, halogen, di-lower alkyl amino; N-lower alkyl-N-lower alkoxy carbonyl lower alkyl amino; N-piperidino; N-morpholino; N-thiomorpholino; lower alkoxy; carboxy lower alkyl thio; benzylthio; and 2H-3-formyl-2-phenyl-1-benzopyran-4-yl-thio; and wherein ring B is unsubstituted and ring A is unsubstituted or substituted at position 8 by lower alkoxy.
Claim 4
Dependent Claim
44 words
The compound of claim 2 which is selected from 3-formyl-4-methoxy-flav-3-ene; 4-ethoxy-3-formyl-flav-3-ene; 3-formyl-4-(N-piperidino)-flav-3-ene; 3-formyl-4-(N-morpholino)-flav-3-ene; 3-formyl-4-(N-thiomorpholino)-flav-3-ene; 4-benzylmercapto-3-formyl-flav-3-ene; 4-(2"H-3"-formyl-2"-phenyl-1"-benzopyran-4"-yl-thio)-3-formyl-flav-3-ene; 4-chloro-3-(alphahydroxyethyl)-flav-3-ene; 4-chloro-3-hydroxyiminomethyl-flav-3-ene; 4-chloro-3-cyano-flav-3-ene; 3-formyl-4-(N-methyl-N-ethoxycarbonylmethylamino)-flav-3-ene; 4-chloro-3-carboxy-flav-3-ene; 4-chloro-3-hydroxymethyl-flav-3-ene; 3-carboxy-flav-3-ene; 4-(S-carboxymethylthio)-3-formyl-flav-3-ene; 4-N,N-dimethylamino-3-formyl-flav-3-ene; 4-methoxy-3-trifluoroacetyl-flav-3-ene; 4-chloro-3-hydroxymethyl-8-methoxy-thioflav-3-ene; 3-carboxy-4-chloro-8-methoxy-thioflav-3-ene; 4-chloro-3-cyano-8-methoxy-thioflav-3-ene; 4-chloro-3-hydroxyiminomethyl-8-methoxy-thioflav-3-ene; 3-chloro-4-hydroxymethyl-flav-3-ene; 4-carboxy-3-chloro-flav-3-ene; 3-methoxy-4-formyl-flav-3-ene; 3-ethoxy-4-formyl-flav-3-ene; 4-formyl-3-(N-piperidino)-flav-3-ene; 4-formyl-3-(N-morpholino)flav-3-ene; 3-benzylmercapto-4-formyl-flav-3-ene; 3-chloro-4-(alpha-hydroxyethyl)-flav-3-ene; 3-chloro-4-hydroxyiminomethylflav-3-ene; 3-chloro-4-cyano-flav-3-ene; 3-(S-carboxymethylthio)-4-formyl-flav-3-ene; 4-formyl-3-(N-thiomorpholino)-flav-3-ene; and 3-N,N-dimethylamino-4-formyl-flav-3-ene.
Claim 5
Dependent Claim
50 words
A compound of claim 1 wherein the radical X 1 is a member selected from said (a) which is bound via a non-carbon atom of said (a) moiety and radical X 2 is a member selected from said (b) which is bound via a carbon atom of said (b) moiety.
Claim 6
Dependent Claim
8 words
The compound of claim 1 which is 3-formyl-4-ethoxy-flav-3-ene.
Claim 7
Dependent Claim
8 words
The compound of claim 1 which is 3-formyl-4-methoxy-flav-3-ene.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-05-11 | 1990-11-10 | 1991-05-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-05-11 | 1994-11-10 | 1995-05-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-05-11 | 1998-11-10 | 1999-05-12 | $7700.00 | Window Closed / Lapsed |